FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070036893> ?p ?o ?g. }

• W2070036893 endingPage "459" @default.
• W2070036893 startingPage "452" @default.
• W2070036893 abstract "Metronomic chemotherapy is the frequent administration of low doses of chemotherapeutic agents targeting tumor‐associated endothelial cells. We examined the efficacy of metronomic irinotecan combined with low‐intensity ultrasound (US) in human uterine sarcoma and evaluated its antiangiogenesis mechanism by measuring the circulating endothelial progenitor cells (CEP), a surrogate marker of angiogenesis. A human uterine sarcoma cell line, FU‐MMT‐3, was used in the present study because this tumor is one of the most malignant neoplasms of human solid tumors and it also has a high angiogenesis property. The combination of low‐dose irinotecan and US irradiation significantly inhibited the tube formation of HUVEC and vascular endothelial growth factor expression of tumor cells in vitro . The FU‐MMT‐3 xenografts in nude mice were treated using US at a low intensity (2.0 w/cm 2 , 1 MHz) for 4 min three times per week each after the intraperitoneal administration of irinotecan; this treatment was continued for 5 weeks. The tumor vascularity was assessed by contrast‐enhanced color Doppler US in real time. The combination treatment significantly inhibited the mobilization of CEP and intratumoral vascularity compared with the control. This combination therapy showed a significant reduction in tumor volume, resulting in a significant prolongation of survival, in comparison with each treatment alone. These results suggest that the effect of metronomic chemotherapy for human uterine sarcoma was accelerated by US irradiation in vivo and this combination might therefore be potentially effective for new cancer therapy. ( Cancer Sci 2011; 102: 452–459)" @default.
• W2070036893 created "2016-06-24" @default.
• W2070036893 creator A5002582387 @default.
• W2070036893 creator A5017737888 @default.
• W2070036893 creator A5026807117 @default.
• W2070036893 creator A5027502054 @default.
• W2070036893 creator A5057393989 @default.
• W2070036893 creator A5081401259 @default.
• W2070036893 creator A5088122735 @default.
• W2070036893 date "2011-01-25" @default.
• W2070036893 modified "2023-10-18" @default.
• W2070036893 title "Metronomic irinotecan chemotherapy combined with ultrasound irradiation for a human uterine sarcoma xenograft" @default.
• W2070036893 cites W1972187137 @default.
• W2070036893 cites W1973261057 @default.
• W2070036893 cites W1977356115 @default.
• W2070036893 cites W1988363709 @default.
• W2070036893 cites W1992552017 @default.
• W2070036893 cites W1997025193 @default.
• W2070036893 cites W1997062281 @default.
• W2070036893 cites W1999746552 @default.
• W2070036893 cites W2009337734 @default.
• W2070036893 cites W2010933562 @default.
• W2070036893 cites W2021679984 @default.
• W2070036893 cites W2049810869 @default.
• W2070036893 cites W2062203795 @default.
• W2070036893 cites W2072176789 @default.
• W2070036893 cites W2075139218 @default.
• W2070036893 cites W2092029860 @default.
• W2070036893 cites W2100945863 @default.
• W2070036893 cites W2102392974 @default.
• W2070036893 cites W2130349349 @default.
• W2070036893 cites W2147711740 @default.
• W2070036893 cites W2169965478 @default.
• W2070036893 cites W2308041362 @default.
• W2070036893 doi "https://doi.org/10.1111/j.1349-7006.2010.01807.x" @default.
• W2070036893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21205068" @default.
• W2070036893 hasPublicationYear "2011" @default.
• W2070036893 type Work @default.
• W2070036893 sameAs 2070036893 @default.
• W2070036893 citedByCount "11" @default.
• W2070036893 countsByYear W20700368932012 @default.
• W2070036893 countsByYear W20700368932013 @default.
• W2070036893 countsByYear W20700368932014 @default.
• W2070036893 countsByYear W20700368932015 @default.
• W2070036893 countsByYear W20700368932018 @default.
• W2070036893 countsByYear W20700368932020 @default.
• W2070036893 crossrefType "journal-article" @default.
• W2070036893 hasAuthorship W2070036893A5002582387 @default.
• W2070036893 hasAuthorship W2070036893A5017737888 @default.
• W2070036893 hasAuthorship W2070036893A5026807117 @default.
• W2070036893 hasAuthorship W2070036893A5027502054 @default.
• W2070036893 hasAuthorship W2070036893A5057393989 @default.
• W2070036893 hasAuthorship W2070036893A5081401259 @default.
• W2070036893 hasAuthorship W2070036893A5088122735 @default.
• W2070036893 hasBestOaLocation W20700368931 @default.
• W2070036893 hasConcept C121608353 @default.
• W2070036893 hasConcept C126322002 @default.
• W2070036893 hasConcept C142724271 @default.
• W2070036893 hasConcept C143998085 @default.
• W2070036893 hasConcept C150903083 @default.
• W2070036893 hasConcept C167734588 @default.
• W2070036893 hasConcept C178596483 @default.
• W2070036893 hasConcept C207001950 @default.
• W2070036893 hasConcept C2776694085 @default.
• W2070036893 hasConcept C2776999253 @default.
• W2070036893 hasConcept C2777025900 @default.
• W2070036893 hasConcept C2777590123 @default.
• W2070036893 hasConcept C2778256501 @default.
• W2070036893 hasConcept C2780259306 @default.
• W2070036893 hasConcept C2780394083 @default.
• W2070036893 hasConcept C502942594 @default.
• W2070036893 hasConcept C526805850 @default.
• W2070036893 hasConcept C71924100 @default.
• W2070036893 hasConcept C86803240 @default.
• W2070036893 hasConceptScore W2070036893C121608353 @default.
• W2070036893 hasConceptScore W2070036893C126322002 @default.
• W2070036893 hasConceptScore W2070036893C142724271 @default.
• W2070036893 hasConceptScore W2070036893C143998085 @default.
• W2070036893 hasConceptScore W2070036893C150903083 @default.
• W2070036893 hasConceptScore W2070036893C167734588 @default.
• W2070036893 hasConceptScore W2070036893C178596483 @default.
• W2070036893 hasConceptScore W2070036893C207001950 @default.
• W2070036893 hasConceptScore W2070036893C2776694085 @default.
• W2070036893 hasConceptScore W2070036893C2776999253 @default.
• W2070036893 hasConceptScore W2070036893C2777025900 @default.
• W2070036893 hasConceptScore W2070036893C2777590123 @default.
• W2070036893 hasConceptScore W2070036893C2778256501 @default.
• W2070036893 hasConceptScore W2070036893C2780259306 @default.
• W2070036893 hasConceptScore W2070036893C2780394083 @default.
• W2070036893 hasConceptScore W2070036893C502942594 @default.
• W2070036893 hasConceptScore W2070036893C526805850 @default.
• W2070036893 hasConceptScore W2070036893C71924100 @default.
• W2070036893 hasConceptScore W2070036893C86803240 @default.
• W2070036893 hasIssue "2" @default.
• W2070036893 hasLocation W20700368931 @default.
• W2070036893 hasLocation W20700368932 @default.
• W2070036893 hasOpenAccess W2070036893 @default.
• W2070036893 hasPrimaryLocation W20700368931 @default.

• next